Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Breelyn A Wilky

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Immunological Reviews|July 30, 2019
Immune checkpoint inhibitors: The linchpins of modern immunotherapyBreelyn A Wilky
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2023
Much Ado about ASPS: The Rapidly Changing Treatment Paradigms of 2022Breelyn A Wilky, Alessandra Maleddu
Current Treatment Options in Oncology|March 10, 2018
Current and Future Directions for Angiosarcoma TherapyVaia Florou, Breelyn A Wilky
Current Treatment Options in Oncology|June 7, 2021
Current Management of Angiosarcoma: Recent Advances and Lessons From the PastVaia Florou, Breelyn A Wilky
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Emerging mechanisms of immunotherapy resistance in sarcomasVaia Florou, Breelyn A Wilky
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2022
Sounding the Alarm on Leiomyosarcoma Recurrence: Role of Circulating Tumor DNABernd Kasper, Breelyn A Wilky
JCO Precision Oncology|February 9, 2022
Emerging Role for Precision Therapy Through Next-Generation Sequencing for SarcomasBreelyn A Wilky, Victor M Villalobos
Current Opinion in Oncology|June 8, 2015
Value added: functional MR imaging in management of bone and soft tissue sarcomasTy K Subhawong, Breelyn A Wilky
Discovery Medicine|April 25, 2014
Immunotherapy in sarcoma: a new frontierBreelyn A Wilky, John M Goldberg
Discovery Medicine|March 1, 2017
From vision to reality: deploying the immune system for treatment of sarcomaBreelyn A Wilky, John M Goldberg
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Immunological Reviews|July 30, 2019
Immune checkpoint inhibitors: The linchpins of modern immunotherapyBreelyn A Wilky
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2023
Much Ado about ASPS: The Rapidly Changing Treatment Paradigms of 2022Breelyn A Wilky, Alessandra Maleddu
Current Treatment Options in Oncology|March 10, 2018
Current and Future Directions for Angiosarcoma TherapyVaia Florou, Breelyn A Wilky
Current Treatment Options in Oncology|June 7, 2021
Current Management of Angiosarcoma: Recent Advances and Lessons From the PastVaia Florou, Breelyn A Wilky
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Emerging mechanisms of immunotherapy resistance in sarcomasVaia Florou, Breelyn A Wilky
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2022
Sounding the Alarm on Leiomyosarcoma Recurrence: Role of Circulating Tumor DNABernd Kasper, Breelyn A Wilky
JCO Precision Oncology|February 9, 2022
Emerging Role for Precision Therapy Through Next-Generation Sequencing for SarcomasBreelyn A Wilky, Victor M Villalobos
Current Opinion in Oncology|June 8, 2015
Value added: functional MR imaging in management of bone and soft tissue sarcomasTy K Subhawong, Breelyn A Wilky
Discovery Medicine|April 25, 2014
Immunotherapy in sarcoma: a new frontierBreelyn A Wilky, John M Goldberg
Discovery Medicine|March 1, 2017
From vision to reality: deploying the immune system for treatment of sarcomaBreelyn A Wilky, John M Goldberg
Pageof 8